Detalhe da pesquisa
1.
Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C).
BMC Gastroenterol
; 22(1): 467, 2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396989
2.
Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy.
AJR Am J Roentgenol
; 209(6): 1278-1284, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29064751
3.
Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.
BJU Int
; 118(2): 264-71, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26573089
4.
An Abundance of Polyps: An Intriguing Case of Lymphomatous Polyposis.
J La State Med Soc
; 167(4): 183-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-27159512
5.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481365
6.
Overall survival and toxicity of hepatocellular carcinoma Barcelona Clinic Liver Cancer B patients receiving Y90 radioembolization: analysis of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
J Gastrointest Oncol
; 14(2): 874-885, 2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201079
7.
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Commun Med (Lond)
; 3(1): 14, 2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750617
8.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062658
9.
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol
; 18(4): 559-570, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369815
10.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530662
11.
The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Crit Rev Oncol Hematol
; 170: 103596, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031442
12.
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.
Eur Urol Focus
; 8(6): 1696-1702, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193819
13.
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.
Clin Genitourin Cancer
; 20(3): 285-295, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305916
14.
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.
Target Oncol
; 17(1): 61-68, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894318
15.
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma.
Eur J Cancer
; 172: 191-198, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780525
16.
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Target Oncol
; 17(5): 571-581, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947324
17.
A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy.
Urology
; 147: 186-191, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203521
18.
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226279
19.
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States.
Clin Genitourin Cancer
; 19(2): e84-e91, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262083
20.
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
Target Oncol
; 16(5): 625-632, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338966